Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Real-time Estimate
Tradegate
13:38:04 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 58.35 EUR | -0.17% |
|
+1.83% | -7.66% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,027B | A | |||||||
| 651B | - | BBB | - | - | ||||
| 467B | AAA | - | ||||||
| 350B | AA | |||||||
| 268B | AAA | |||||||
| 257B | A | |||||||
| 205B | A | |||||||
| 190B | BBB | |||||||
| 187B | AA | |||||||
| 158B | A | |||||||
| 131B | AA | |||||||
| 128B | A | |||||||
| 104B | A | |||||||
| 102B | AA | |||||||
| 70.58B | AA | |||||||
| 60.94B | AA | |||||||
| 55.31B | AA | |||||||
| 45.67B | A | - | - | - | ||||
| 42.47B | AA | |||||||
| Average | 236.79B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
